#215 - Protect Your Benefits From Devastating Pharma Ads

The $6 Billion Influence Machine Targeting Your Benefits Plan

Featuring Kyra Hagan, Senior Vice President of Marketing, RxBenefits.

Six billion dollars. That is what pharmaceutical companies spend every year marketing high-cost, high-profit prescription drugs directly to your employees — and the clinical and financial consequences are landing squarely on your health plan.

Bo sits down with Kyra Hagan, a 25-year healthcare industry veteran and SVP of Marketing at ASHHRA Platinum Sponsor RxBenefits, to unpack the direct-to-consumer advertising machine and why healthcare HR leaders need to understand how it works.

📺 How DTC Advertising Shapes Member Behavior Pharma spends heavily to drive patients to ask for brand-name drugs by name. Studies show 7 in 10 consumers will request a drug by name after seeing ads. About 40% of those scripts get filled — often with no clinical necessity and no cost comparison. Prescribers, motivated by compassion, frequently write the script for the asking.

💊 GLP-1s, Biologics & the Highest-Risk Therapeutic Classes Chronic conditions — diabetes, autoimmune disorders, mental health — are the primary targets. GLP-1s like Ozempic and Wegovy have exploded into a projected $60B market by 2030, creating significant plan exposure. One branded arthritis drug costs $2,800/month. The two over-the-counter equivalents it combines cost $17.

🏥 The HR Leader's Dilemma Plan sponsors live in a bifurcated world: contain costs for the CFO while protecting the benefits that recruit and retain top talent. Without a partner actively managing formulary, step therapy, and clinical utilization, one new hire or one new drug to market can create a catastrophic claim.

🔎 What HR Leaders Should Do Now

• Audit your PBM relationship — misaligned incentives may be driving spend, not containing it
• Ensure your pharmacy partner uses independent clinical rigor, not rebate-driven decisions
• Leverage plan data analytics to identify trending therapeutic classes before spend spikes
• Educate members on DTC advertising and the cost and clinical value of alternatives

You are always one diagnosis, one new drug, one new hire away from a catastrophic claim. The right pharmacy advocate changes that equation.